Trinity Biotech PLC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Novus Diagnostics Ltd. has reported a 5.99% beneficial ownership stake in Trinity Biotech PLC, holding 1,119,988 American Depositary Shares.